{"company":{"id":686675,"name":"Tango Therapeutics","domain":"tangotherapeutics.com","url":"https://alion.io/company/tangotherapeutics"},"answer":"As of Nov 16, 2026, Alion lists 10 companies most like Tango Therapeutics: Erasca, Immunome, Replimune, SystImmune, Entrada Therapeutics, Real, NUVATION BIO, Celcuity, Exelixis and Revolution Medicines.","highlights":["Tango Therapeutics itself has 11 open roles on Alion.","Of them, Revolution Medicines is hiring the most, with 210 open roles.","NUVATION BIO has raised the most venture funding on record: $275.3M."],"as_of":"2026-11-16","cite":"Alion, \"Tango Therapeutics competitors and alternatives: 10 similar companies compared on hiring and funding\", as of Nov 16, 2026. https://alion.io/company/tangotherapeutics/competitors","indexable":true,"target":{"name":"Tango Therapeutics","url":"https://alion.io/company/tangotherapeutics","domain":"tangotherapeutics.com","open_roles":11,"open_roles_change":null,"funding":{"total_raised_usd":95016599,"last_round":"venture","last_round_usd":14999995,"last_round_date":"2025-10-24","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","CAPA","GLP"],"hiring_countries":["US"],"similarity":null},"competitors":[{"name":"Erasca","url":"https://alion.io/company/erasca","domain":"erasca.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"San Diego","country":"US"},"technologies":["GCP","SAS","Mandiant capa"],"hiring_countries":["US"],"similarity":{"score":15.72,"shared_segments":["Oncology Therapeutics","Precision Medicine"],"shared_technologies":["GCP","Mandiant capa","SAS","GMP","Good Clinical Practice"],"same_hq_country":true}},{"name":"Immunome","url":"https://alion.io/company/immunome","domain":"immunome.com","open_roles":50,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Bothell","country":"US"},"technologies":["GCP","SAS","GMP"],"hiring_countries":["US"],"similarity":{"score":14.35,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","GCP","SAS","GMP","GLP"],"same_hq_country":true}},{"name":"Replimune","url":"https://alion.io/company/replimune","domain":"replimune.com","open_roles":27,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Woburn","country":"US"},"technologies":["PyTorch","GMP","GCP"],"hiring_countries":["US","GB"],"similarity":{"score":13.6,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","SQL","GCP","Mandiant capa","SAS"],"same_hq_country":true}},{"name":"SystImmune","url":"https://alion.io/company/systimmune","domain":"systimmune.com","open_roles":45,"open_roles_change":null,"funding":{"total_raised_usd":7176168,"last_round":"convertible_note","last_round_usd":7176168,"last_round_date":"2024-05-28","lead_investors":[]},"size_band":"201-500","headquarters":{"city":"Redmond","country":"US"},"technologies":["Cell Culture","Flow Cytometry","Antibody Engineering"],"hiring_countries":["US"],"similarity":{"score":13.5,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","SQL","GCP","SAS","GMP"],"same_hq_country":true}},{"name":"Entrada Therapeutics","url":"https://alion.io/company/entrada-therapeutics","domain":"entradatx.com","open_roles":6,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Boston","country":"US"},"technologies":["GCP","SAS","Python"],"hiring_countries":["US"],"similarity":{"score":12.75,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","GCP","SAS","GMP","CAPA"],"same_hq_country":true}},{"name":"Real","url":"https://alion.io/company/exvadebio","domain":"exvadebio.com","open_roles":0,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Atlanta","country":"US"},"technologies":[],"hiring_countries":[],"similarity":{"score":12.67,"shared_segments":["Precision Medicine","Oncology Therapeutics"],"shared_technologies":[],"same_hq_country":true}},{"name":"NUVATION BIO","url":"https://alion.io/company/nuvationbio","domain":"nuvationbio.com","open_roles":4,"open_roles_change":null,"funding":{"total_raised_usd":275348195,"last_round":"venture","last_round_usd":275348195,"last_round_date":"2019-06-17","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"New York","country":"US"},"technologies":["GMP","Good Clinical Practice","GLP"],"hiring_countries":["US","CN"],"similarity":{"score":12.35,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["GCP","GMP","GLP","Good Clinical Practice"],"same_hq_country":true}},{"name":"Celcuity","url":"https://alion.io/company/celcuity","domain":"celcuity.com","open_roles":3,"open_roles_change":null,"funding":{"total_raised_usd":169027061,"last_round":"convertible_note","last_round_usd":50000000,"last_round_date":"2023-10-20","lead_investors":[]},"size_band":"51-200","headquarters":{"city":"Minneapolis","country":"US"},"technologies":["GLP","JMP","ICH Guidelines"],"hiring_countries":["US"],"similarity":{"score":12.35,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","GCP","GLP","ICH Guidelines"],"same_hq_country":true}},{"name":"Exelixis","url":"https://alion.io/company/exelixis-com","domain":"exelixis.com","open_roles":61,"open_roles_change":null,"funding":{"total_raised_usd":null,"last_round":null,"last_round_usd":null,"last_round_date":null,"lead_investors":[]},"size_band":"1001-5000","headquarters":{"city":"Alameda","country":"US"},"technologies":["AWS","CI/CD","Python"],"hiring_countries":["US"],"similarity":{"score":12.25,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","SQL","GCP","Mandiant capa","SAS"],"same_hq_country":true}},{"name":"Revolution Medicines","url":"https://alion.io/company/revolution-medicines","domain":"revmed.com","open_roles":210,"open_roles_change":null,"funding":{"total_raised_usd":204242977,"last_round":"venture","last_round_usd":100287058,"last_round_date":"2019-06-05","lead_investors":[]},"size_band":"501-1000","headquarters":{"city":"Redwood City","country":"US"},"technologies":["GCP","Python","Machine Learning"],"hiring_countries":["US","ES","JP"],"similarity":{"score":12.18,"shared_segments":["Oncology Therapeutics"],"shared_technologies":["Python","SQL","GCP","SAS","GMP"],"same_hq_country":true}}],"method":"Ranked by Alion's similar-companies engine (the MCP tool similar_companies): shared industry segments and the overlap of the two segment sets, technologies named in both companies' job postings, the same headquarters country, a size band near it. Open roles are the visible postings on Alion today; their change is shown only for boards that state posting dates.","html_url":"https://alion.io/company/tangotherapeutics/competitors","json_url":"https://alion.io/company/tangotherapeutics/competitors.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","built_at":"2026-11-16T03:07:55Z","generated_at":"2026-11-20T19:46:53Z"}}